As of 2025-09-13, the Relative Valuation of Bioventus Inc (BVS) is (0.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.28 USD, the upside of Bioventus Inc based on Relative Valuation is -100.4%.
The range of the Relative Valuation is (0.03) - (0.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 25.7x | 16.0x |
| Forward P/E multiples | 13.2x - 21.1x | 16.5x |
| Fair Price | (0.03) - (0.04) | (0.03) |
| Upside | -100.3% - -100.6% | -100.4% |
| Date | P/E |
| 2025-09-11 | -3,809.56 |
| 2025-09-10 | -3,663.04 |
| 2025-09-09 | -3,804.33 |
| 2025-09-08 | -3,772.93 |
| 2025-09-05 | -3,762.46 |
| 2025-09-04 | -3,715.37 |
| 2025-09-03 | -3,683.97 |
| 2025-09-02 | -3,778.16 |
| 2025-08-29 | -3,872.35 |
| 2025-08-28 | -3,793.86 |
| 2025-08-27 | -3,919.45 |
| 2025-08-26 | -3,804.33 |
| 2025-08-25 | -3,893.29 |
| 2025-08-22 | -3,997.94 |
| 2025-08-21 | -3,704.90 |
| 2025-08-20 | -3,772.93 |
| 2025-08-19 | -3,830.49 |
| 2025-08-18 | -3,757.23 |
| 2025-08-15 | -3,856.66 |
| 2025-08-14 | -3,840.96 |
| 2025-08-13 | -3,940.38 |
| 2025-08-12 | -3,825.26 |
| 2025-08-11 | -3,626.41 |
| 2025-08-08 | -3,621.17 |
| 2025-08-07 | -3,626.41 |
| 2025-08-06 | -3,814.79 |
| 2025-08-05 | -3,213.01 |
| 2025-08-04 | -3,307.20 |
| 2025-08-01 | -3,233.94 |
| 2025-07-31 | -3,411.86 |
| 2025-07-30 | -3,422.32 |
| 2025-07-29 | -3,422.32 |
| 2025-07-28 | -3,417.09 |
| 2025-07-25 | -3,438.02 |
| 2025-07-24 | -3,349.06 |
| 2025-07-23 | -3,385.69 |
| 2025-07-22 | -3,369.99 |
| 2025-07-21 | -3,296.73 |
| 2025-07-18 | -3,275.80 |
| 2025-07-17 | -3,396.16 |
| 2025-07-16 | -3,474.65 |
| 2025-07-15 | -3,453.72 |
| 2025-07-14 | -3,563.61 |
| 2025-07-11 | -3,647.34 |
| 2025-07-10 | -3,867.12 |
| 2025-07-09 | -3,830.49 |
| 2025-07-08 | -3,699.67 |
| 2025-07-07 | -3,568.85 |
| 2025-07-03 | -3,673.50 |
| 2025-07-02 | -3,584.54 |